Abbott India Limited
Abbott India Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: ABBOTINDIA and BSE: 500488 (ISIN INE358A01014).
It has a market capitalisation of ₹55,048 crore, a last close of ₹25,905 on 2026-10-19, a one-year return of -13.1%.
Valuation: a price-to-earnings ratio of 34.09x, a price-to-book ratio of 11.53x, a dividend yield of 2.0%.
Profitability: return on equity of 34.5%, return on capital employed of 44.1%, an operating margin of 28.1%.
Growth: sales growth of 9.0% a year over three years, net profit growth of 17.8% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x.
| Metric | Value |
|---|---|
| Market capitalisation | 55,048 |
| Last close | ₹25,905 |
| P/E (TTM) | 34.09x |
| P/B | 11.53x |
| Dividend yield | 2.0% |
| ROE (FY) | 34.5% |
| ROCE (FY) | 44.1% |
| Operating margin (TTM) | 28.1% |
| Sales growth, 3-year CAGR | 9.0% |
| Profit growth, 3-year CAGR | 17.8% |
| Debt / equity | 0.00x |
| 1-year return | -13.1% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means